FY 2025 and 2026 appropriations for the development of a synthetic vaccine
2025 · 1st Quarter (Jan 1 - Mar 31)
THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES
Filed by MAGILL ASSOCIATES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 1, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- MAGILL ASSOCIATES, LLC
- Filing UUID
- bb835152-1ca1-4ae4-afdb-59c9cffbb047
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
FY 2025 and 2026 appropriations for the development of a synthetic vaccine
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.